Hykes Andrew's Form 4 filing
Inari Medical, Inc. (NARI) · filed Dec 20, 2024
- Accession no.
- 0001127602-24-029927
- Filed
- Dec 20, 2024
- Trade date
- Dec 20, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $165.9K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hykes AndrewCIK 0001806431 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 20, 2024 | Common Stock | SSaleDisposed | −2,400 | $55.20 | −$132,480 | 439,910 | Direct | |
| Dec 20, 2024 | Common Stock | SSaleDisposed | −600 | $55.65 | −$33,390 | 439,310 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.